SCHEMBL20154111

SCHEMBL20154111

COc1ccc(CN/C=C(/C)C=N)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
PKM P14618 1/20 0.47
HPGD P15428 2/20 0.46
USP2 O75604 1/20 0.44
TP53 P04637 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP3A4 P08684 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
ALOX12 P18054 1/20 0.43
CHRM2 P08172 1/20 0.42
NPC1 O15118 2/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24014177 0.83 ALDH1A1 (0.50) ALDH1A1PKMHPGDUSP2TP53
SCHEMBL21872429 0.82 ALDH1A1 (0.47) ALDH1A1PKMHPGDUSP2TP53
SCHEMBL21872305 0.79 ALDH1A1 (0.47) ALDH1A1PKMHPGDUSP2TP53
SCHEMBL19300116 0.78 HPGD (0.44) ALDH1A1PKMHPGDUSP2TP53
SCHEMBL4509618 0.77 ALDH1A1 (0.51) ALDH1A1PKMHPGDUSP2SMN1; SMN2
SCHEMBL23431409 0.76 HDAC1 (0.47) ALDH1A1ALOX15NPC1MEN1MAPT
SCHEMBL21872290 0.76 ALDH1A1 (0.44) ALDH1A1PKMHPGDUSP2TP53
SCHEMBL20229846 0.76 ALDH1A1 (0.43) ALDH1A1PKMHPGDUSP2TP53
SCHEMBL18600020 0.75 ALDH1A1 (0.51) ALDH1A1PKMHPGDSMN1; SMN2NPC1
SCHEMBL21872289 0.74 ALDH1A1 (0.42) ALDH1A1PKMHPGDUSP2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022073469-A1 COMPOUNDS AND METHODS OF TREATING CANCERS CULLGEN (SHANGHAI) , INC. (CN) 2022-04-14 WO disclosed
EP-3538523-B1 PYRIMIDINONE DERIVATIVES AS CDC7 INHIBITORS CANCER RESEARCH TECH LTD (GB) 2021-05-19 EP disclosed
WO-2018087527-A1 PYRIMIDINONE DERIVATIVES AS CDC7 INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2018-05-17 WO disclosed